Gilberto Vargas-Alarcón Selected Research

Phosphodiesterase I (5' Exonuclease)

2/2015	Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
9/2014	IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: the genetics of atherosclerotic disease Mexican study.
1/2013	Single nucleotide polymorphisms within LIPA (Lysosomal Acid Lipase A) gene are associated with susceptibility to premature coronary artery disease. a replication in the genetic of atherosclerotic disease (GEA) Mexican study.
1/2012	The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilberto Vargas-Alarcón Research Topics

Disease

24	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2006
22	Atherosclerosis 06/2022 - 01/2013
15	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 01/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 01/2008
11	Hypertension (High Blood Pressure) 11/2021 - 03/2012
9	Acute Coronary Syndrome 01/2021 - 10/2010
8	Insulin Resistance 01/2022 - 01/2015
8	Obesity 11/2020 - 06/2014
7	Fatty Liver 11/2021 - 02/2015
6	Atherosclerotic Plaque (Atheroma) 11/2020 - 01/2009
6	Type 2 Diabetes Mellitus (MODY) 11/2019 - 02/2007
5	Inflammation (Inflammations) 11/2020 - 02/2008
5	Myocardial Infarction 07/2020 - 10/2008
5	Coronary Disease (Coronary Heart Disease) 01/2020 - 10/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2017 - 01/2011
5	Ulcerative Colitis 01/2016 - 08/2004
4	Dyslipidemias (Dyslipidemia) 01/2021 - 09/2014
4	Infections 09/2013 - 01/2004
4	Takayasu Arteritis (Arteritis, Takayasu's) 07/2013 - 01/2005
3	COVID-19 01/2022 - 07/2021
3	Hypertriglyceridemia 01/2021 - 01/2018
3	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 01/2021 - 11/2020
3	Hyperuricemia 01/2021 - 09/2014
3	Abdominal Obesity 01/2018 - 01/2017
3	Proteinuria 03/2016 - 12/2012
3	Tuberculosis (Tuberculoses) 09/2013 - 05/2007
2	Magnesium Deficiency (Deficiency, Magnesium) 01/2022 - 01/2021
2	Dementia (Dementias) 01/2021 - 01/2016
2	Hypercholesterolemia 10/2020 - 08/2015
2	Coronary Restenosis 03/2019 - 11/2008
2	Systemic Scleroderma (Systemic Sclerosis) 07/2016 - 01/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 01/2013
2	Essential Hypertension 01/2016 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 12/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 10/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2009 - 07/2007
2	Fibromyalgia (Fibrositis) 07/2009 - 01/2007
2	Ankylosing Spondylitis 10/2006 - 12/2004

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 01/2021 - 10/2006
12	CytokinesIBA 06/2021 - 12/2007
11	HDL CholesterolIBA 01/2022 - 06/2014
10	CholesterolIBA 01/2022 - 01/2011
9	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2011
9	Proteins (Proteins, Gene)FDA Link 07/2018 - 12/2004
7	Interleukin-10 (Interleukin 10)IBA 01/2022 - 07/2011
7	AdiponectinIBA 01/2021 - 01/2015
6	ApolipoproteinsIBA 11/2021 - 01/2008
6	InterleukinsIBA 06/2021 - 01/2013
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011 - 08/2003
5	CalciumIBA 04/2021 - 05/2017
5	HDL LipoproteinsIBA 07/2019 - 04/2012
5	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 09/2014
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2015 - 07/2002
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2014 - 10/2006
5	HLA-B Antigens (HLA-B)IBA 11/2009 - 01/2004
4	oxidized low density lipoproteinIBA 01/2022 - 06/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2010
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2017 - 02/2015
4	Phosphodiesterase I (5' Exonuclease)IBA 02/2015 - 01/2012
4	HLA-DRB1 Chains (HLA DRB1)IBA 11/2009 - 01/2003
4	HLA-DR Antigens (HLA-DR)IBA 01/2009 - 01/2004
3	OsteoprotegerinIBA 06/2022 - 08/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2018
3	OsteopontinIBA 11/2021 - 08/2017
3	Alkaline PhosphataseIBA 06/2021 - 09/2014
3	Genetic Markers (Genetic Marker)IBA 04/2021 - 01/2009
3	Interleukin-15 (Interleukin 15)IBA 01/2021 - 01/2014
3	Interleukin-27 (Interleukin 27)IBA 01/2019 - 01/2016
3	Lipoproteins (Lipoprotein)IBA 01/2018 - 08/2017
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018 - 09/2014
3	Insulin (Novolin)FDA Link 04/2017 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2015
3	CreatinineIBA 09/2016 - 12/2012
3	Nonesterified Fatty Acids (NEFA)IBA 01/2016 - 02/2015
3	HLA-A Antigens (HLA-A)IBA 04/2015 - 01/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2009
3	Ion Channels (Ion Channel)IBA 01/2015 - 07/2006
3	Interleukin-1 (Interleukin 1)IBA 07/2013 - 10/2010
3	Apolipoproteins E (ApoE)IBA 10/2010 - 01/2008
2	EnzymesIBA 06/2021 - 01/2013
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2021 - 01/2007
2	Lipoprotein(a)IBA 01/2020 - 01/2018
2	interleukin 20 (IL-20)IBA 01/2020 - 01/2013
2	Uric Acid (Urate)IBA 03/2019 - 12/2017
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 07/2009
2	Vitamin D FDA LinkGeneric 01/2018 - 11/2016
2	Messenger RNA (mRNA)IBA 08/2017 - 01/2017
2	Heme Oxygenase-1IBA 01/2017 - 01/2016
2	ThioredoxinsIBA 01/2017 - 01/2016
2	Aryldialkylphosphatase (Paraoxonase)IBA 03/2016 - 10/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 02/2015 - 04/2012
2	AutoantibodiesIBA 01/2015 - 01/2009
2	Matrix Metalloproteinases (MMPs)IBA 11/2013 - 01/2012
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2013 - 10/2010
2	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2012 - 01/2011
2	GelsIBA 04/2012 - 01/2011
2	polyacrylamideIBA 04/2012 - 01/2011
2	HLA-DQB1 antigen (HLA DQB1)IBA 11/2009 - 05/2004
2	HLA-DQbeta antigenIBA 02/2007 - 05/2004

Therapy/Procedure

6	Stents 01/2022 - 02/2008